[1]
R. P. Baughman, E. E. Lower, D. A. Culver, M. A. Judson, and A. U. Wells, “WASOG Clinical Trial Endpoint Task Force: Executive Summary”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 42, no. 3, p. 17859, Sep. 2025, doi: 10.36141/svdld.v42i3.17859.